|
Boston,
Massachusetts, March 9, 2009.
CompuCyte
Corporation and the Program in Cellular and Molecular Medicine
at Children’s Hospital Boston (also known as the Immune Disease
Institute) today announced the establishment of a joint
Quantitative Imaging Cytometry program. The Program in Cellular
and Molecular Medicine is an affiliate of Harvard Medical School
(HMS) and is located in the Longwood Medical Area. Under the
terms of the agreement, CompuCyte will make its proprietary
laser scanning cytometry instrumentation and technical support
programs available to trained personnel, and will provide
quantitative imaging cytometry and analysis services to the
larger Longwood Medical Area community.
“The joint
program with CompuCyte gives our facility a new and powerful
asset to offer the HMS research community. CompuCyte’s
instrumentation provides the ability to combine the quantitative
data traditionally generated through flow cytometry with
laser-scanned images of cells and tissues, without the customary
flow requirement for harsh sample-processing and the unwanted
disturbance of native cells and tissue architecture normally
associated with traditional cytometry,” explained Dr. Natasha
Barteneva, Director of the Flow and Imaging Cytometry Resource
of the Program in Cellular and Molecular Medicine and manager of
the joint program. “The agreement with CompuCyte expands our
capacity in quantitative imaging cytometry and reinforces our
commitment to providing our researchers access to the most
advanced analytical technologies,” stated Dr. Margaret Bradley,
Chief Scientific Administrative Officer.
“Laser
Scanning Cytometry (LSC) technology has become a gold standard
in quantitative automated analysis of intact adherent cells,
tissue specimens, tissue microarrays and small cellular samples,
such as small needle aspirates,” explained Dr. Elena Holden,
CompuCyte’s President and Chief Executive Officer. ”The
reputation of the Program in Cellular and Molecular Medicine for
quality and scientific vigor is well known. We are enthusiastic
about the opportunity to collaborate with their Flow and Imaging
Cytometry Resource and to add our proprietary LSC technology to
their existing infrastructure.”
The Program
in Cellular and Molecular Medicine at Children’s Hospital Boston
(also known as the Immune Disease Institute) is a non-profit
research institution academically affiliated with Harvard
Medical School, recognized worldwide for its discoveries that
increase the body's ability to fight disease. Its mission is
fundamental biomedical research to improve human health, harness
inflammation, and strengthen immune defense.
CompuCyte
Corporation, a private company headquartered in Westwood,
Massachusetts, is a pioneer and leader in the development of
quantitative imaging cytometry instrumentation based on patented
laser scanning cytometry technology. The company’s iCyte®,
iCys®, and iColor® cytometers enable true
quantitative cytometric image analysis of cellular and tissue
specimens in life science research, drug safety, toxicology
studies, biomarker discovery and clinical trials. |
